| Combination of rhamnolipid and chitosan in nanoparticles boosts their antimicrobial efficacy CA Marangon, VCA Martins, MH Ling, CC Melo, AMG Plepis, RL Meyer, ... ACS Applied Materials & Interfaces 12 (5), 5488-5499, 2020 | 121 | 2020 |
| Reproducibility of Fluorescent Expression from Engineered Biological Constructs in E. coli J Beal, T Haddock-Angelli, M Gershater, K De Mora, M Lizarazo, ... PloS one 11 (3), e0150182, 2016 | 56 | 2016 |
| Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy AC Fux, C Casonato Melo, S Michelini, BJ Swartzwelter, A Neusch, ... International Journal of Molecular Sciences 24 (9), 8395, 2023 | 27 | 2023 |
| Reaching Biocompatibility with Nanoclays: Eliminating the Cytotoxicity of Ir (III) Complexes MC Grüner, KPS Zanoni, CF Borgognoni, CC Melo, V Zucolotto, ... ACS applied materials & interfaces 10 (32), 26830-26834, 2018 | 19 | 2018 |
| Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates C Casonato Melo, AC Fux, M Himly, NG Bastús, L Schlahsa, C Siewert, ... International Journal of Molecular Sciences 24 (18), 13971, 2023 | 2 | 2023 |
| Artificial Targets: a versatile cell-free platform to characterize CAR T cell function in vitro X Wang, NJA Tokarew, R Siemer, CC Melo, T Cathomen, I Gessner, ... Frontiers in Immunology 15, 1254162, 2024 | 1 | 2024 |
| Generation of Endotoxin-Specific Monoclonal Antibodies by Phage and Yeast Display for Capturing Endotoxin AC Fux, C Casonato Melo, L Schlahsa, NB Burzan, A Felsberger, ... International Journal of Molecular Sciences 25 (4), 2297, 2024 | 1 | 2024 |
| Nanopartículas de quitosana como veículo para entrega de oligodeoxiribonucleotídeos antisense CC Melo Universidade de São Paulo, 2018 | 1 | 2018 |
